Atorvastatin Calcium Inhibits PDGF-ββ-Induced Proliferation and Migration of VSMCs Through the G0/G1 Cell Cycle Arrest and Suppression of Activated PDGFRβ-PI3K-Akt Signaling Cascade

被引:24
作者
Chen, Shuang [1 ]
Dong, Siyuan [2 ]
Li, Zhao [1 ]
Guo, Xiaofan [1 ]
Zhang, Naijin [1 ]
Yu, Bo [3 ,4 ]
Sun, Yingxian [1 ]
机构
[1] China Med Univ, Dept Cardiol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China
[2] China Med Univ, Dept Thorac Surg, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin, Heilongjiang, Peoples R China
[4] Harbin Med Univ, Key Lab Myocardial Ischemia, Minist Educ, Harbin, Heilongjiang, Peoples R China
关键词
Vascular smooth muscle cells; PDGF-beta beta; Atorvastatin calcium; Akt; VASCULAR SMOOTH-MUSCLE; GROWTH-FACTOR; NEOINTIMAL HYPERPLASIA; TRANSDUCTION PATHWAYS; INTIMAL HYPERPLASIA; PORCINE CORONARY; ATHEROSCLEROSIS; INJURY; PROGRESSION; PROTEIN;
D O I
10.1159/000484648
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: Abnormal proliferation of vascular smooth muscle cells (VSMCs) is a hallmark of vascular lesions, such as atherosclerosis and restenosis. PDGF-beta beta, an isoform of PDGF (platelet-derived growth factor), has been demonstrated to induce proliferation and migration of VSMCs. Atorvastatin calcium, a selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, has favorable protective effects on VSMCs. This study examined the effects of atorvastatin calcium on the proliferation and migration of PDGF-beta beta-treated VSMCs, as well as its underlying mechanisms. Methods: MTT assays, Edu imaging, cell cycle analysis, wound healing assays, transwell migration assays, and western blot analysis were performed. Results: Atorvastatin calcium significantly inhibited cell proliferation, DNA synthesis and cell migration of PDGF-beta beta-treated VSMCs. We demonstrated that atorvastatin calcium induced cell cycle arrest in the G0/G1 phase in response to PDGF-beta beta stimulation and decreased the expression of G0/G1-specific regulatory proteins, including proliferating cell nuclear antigen (PCNA), CDK2, cyclin D1, cyclin E and CDK4 in PDGF-beta beta-treated VSMCs. Moreover, pretreatment with atorvastatin calcium inhibited the PDGF-beta beta-treated phosphorylation of PDGFR beta and Akt, whereas atorvastatin calcium did not affect the phosphorylation of PLC-gamma 1 or (ERK) 1/2. Conclusion: Our data suggested that atorvastatin calcium inhibited abnormal proliferation and migration of VSMCs through G0/G1 cell cycle arrest and suppression of the PDGFR beta-Akt signaling cascade. (c) 2017 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:215 / 228
页数:14
相关论文
共 49 条
[31]  
2-I
[32]  
Owens GK, 1997, AGENT ACTION SUPPL, V48, P3
[33]   Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration [J].
Porter, KE ;
Naik, J ;
Turner, NA ;
Dickinson, T ;
Thompson, MM ;
London, NJM .
JOURNAL OF VASCULAR SURGERY, 2002, 36 (01) :150-157
[34]  
Pyles JM, 1997, CIRC RES, V81, P904
[35]   PDGF and cardiovascular disease [J].
Raines, EW .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) :237-254
[36]  
Ross R, 1990, Adv Nephrol Necker Hosp, V19, P79
[37]   THE PATHOGENESIS OF ATHEROSCLEROSIS - A PERSPECTIVE FOR THE 1990S [J].
ROSS, R .
NATURE, 1993, 362 (6423) :801-809
[38]   Regulation of vascular smooth muscle cell differentiation [J].
Rzucidlo, Eva M. ;
Martin, Kathleen A. ;
Powell, Richard J. .
JOURNAL OF VASCULAR SURGERY, 2007, 45 :25A-32A
[39]  
SACHINIDIS A, 1990, J BIOL CHEM, V265, P10238
[40]  
SASAGURI Y, 1994, LAB INVEST, V71, P261